4//SEC Filing
MELTZER LESLIE 4
Accession 0001127602-25-021056
CIK 0001492422other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 10:13 AM ET
Size
7.0 KB
Accession
0001127602-25-021056
Insider Transaction Report
Form 4
MELTZER LESLIE
Chief Research and Development
Transactions
- Award
Common Stock
2025-08-26+61,804→ 61,804 total - Award
Stock Option (Right to Buy)
2025-08-26+92,592→ 92,592 totalExercise: $16.20Exp: 2035-08-26→ Common Stock (92,592 underlying)
Footnotes (2)
- [F1]This restricted stock unit was granted on August 26, 2025. The restricted stock unit will vest 25% annually over four years from grant date, subject to her continued service as an officer, or upon later termination of her service.
- [F2]This represents a stock option award granted August 26, 2025 that vests over a four-year period. 25% vests one year from grant date and the remaining 75% vests monthly thereafter subject to continued service.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0002084030
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 10:13 AM ET
- Size
- 7.0 KB